author-photo

Francis Mark Senecal

9

Papers

69

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Final efficacy results of neratinib in HER2-positive hormone receptor-positive early-stage breast cancer from the phase III ExteNET trial

2020 Clinical Breast Cancer
Show All
- Source
- Cite
- Save
Citations (32)
Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (10)
Duration of extended adjuvant therapy with neratinib in early-stage HER2+ breast cancer after trastuzumab-based therapy: Exploratory analyses from the phase III ExteNET trial.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Participant Attitudes Toward an Intensive Trial of Multiple Biopsies, Multidimensional Molecular Analysis, and Reporting of Results in Metastatic Triple-Negative Breast Cancer

2017
Show All
- Source
- Cite
- Save
Citations (1)
A Distributed Network for Intensive Longitudinal Monitoring in Metastatic Triple-Negative Breast Cancer

2016 Journal of The National Comprehensive Cancer Network
Show All
- Source
- Cite
- Save
Citations (16)
Trabectedin (T)-related liver toxicity: Results of a pharmacokinetic study with T in patients with hepatic dysfunction (OVC1004) and experience from a phase 3 clinical trial (SAR3007).

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)